Literature DB >> 21383327

Cortical lesions in children with multiple sclerosis.

M Absinta1, M A Rocca, L Moiola, M Copetti, N Milani, A Falini, G Comi, M Filippi.   

Abstract

OBJECTIVE: Double inversion recovery (DIR) sequences have improved the detection of cortical lesions (CLs) in adult patients with multiple sclerosis (MS). We evaluated the presence and frequency of CLs in pediatric patients with relapsing-remitting MS (RRMS) in comparison to adult patients with MS with the same clinical phenotype.
METHODS: Using a 3.0-T scanner, brain DIR, dual-echo, and 3-dimensional T1-weighted scans were acquired from 24 pediatric patients with RRMS, 15 adult patients with RRMS, and 10 pediatric healthy controls. CLs and white matter (WM) lesions were identified, and their volumes measured. Brain gray matter and WM volumes were also calculated. Between-group comparisons were performed using χ(2), Mann-Whitney, and analysis of variance tests. Poisson regressions for count data were used to model the number of lesions of the 2 groups of patients.
RESULTS: Compared to adults, pediatric patients had shorter disease duration and lower disability. WM lesion number and volume did not differ between pediatric and adult patients with MS. CLs were detected in 2 (8%) pediatric and 10 (66%) adult patients. Median CL volume was lower in pediatric than adult patients with RRMS (p = 0.0003). Regression analysis showed that pediatric patients had a lower number of CLs than adults (p = 0.0003), after adjusting for age, gender, Expanded Disability Status Scale score, and disease duration.
CONCLUSION: CLs are rare in pediatric patients with MS. Since pediatric patients with MS have a clinical onset closer to the biological onset of the disease than adult patients with MS, our findings indicate that CL formation is likely not to be an initial event in this disease.

Entities:  

Mesh:

Year:  2011        PMID: 21383327     DOI: 10.1212/WNL.0b013e31820f2e69

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Authors:  Sniya Valsa Sudhakar; Karthik Muthusamy; Sunithi Mani; Sridhar Gibikote; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

2.  Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.

Authors:  Maria A Rocca; Paola Valsasina; Martina Absinta; Lucia Moiola; Angelo Ghezzi; Pierangelo Veggiotti; Maria P Amato; Mark A Horsfield; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

3.  Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.

Authors:  E S Beck; P Sati; V Sethi; T Kober; B Dewey; P Bhargava; G Nair; I C Cortese; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2018-02-08       Impact factor: 3.825

4.  White matter dementia.

Authors:  Christopher M Filley
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

5.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

6.  7T MRI Visualization of Cortical Lesions in Adolescents and Young Adults with Pediatric-Onset Multiple Sclerosis.

Authors:  Ritobrato Datta; Varun Sethi; Sophia Ly; Amy T Waldman; Sona Narula; Blake E Dewey; Pascal Sati; Daniel Reich; Brenda Banwell
Journal:  J Neuroimaging       Date:  2017-08-10       Impact factor: 2.486

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 8.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

9.  International Pediatric MS Study Group Clinical Trials Summit: meeting report.

Authors:  Tanuja Chitnis; Marc Tardieu; Maria Pia Amato; Brenda Banwell; Amit Bar-Or; Angelo Ghezzi; Andrew Kornberg; Lauren B Krupp; Daniela Pohl; Kevin Rostasy; Silvia Tenembaum; Emmanuelle Waubant; Evangeline Wassmer
Journal:  Neurology       Date:  2013-03-19       Impact factor: 9.910

10.  MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.

Authors:  Josefina Maranzano; David A Rudko; Kunio Nakamura; Stuart Cook; Diego Cadavid; Leo Wolansky; Douglas L Arnold; Sridar Narayanan
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.